Home › Sjogren's Syndrome › Massachusetts › Boston
Sjogren's Syndrome clinical trials in Boston, MA
5 studies for Sjogren's Syndrome are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RecruitingPhase 1
- Massachusetts General Hospital Cancer Center, Boston
- Dana-Farber Cancer Institute, Boston
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
RecruitingPhase 3
- Tufts Medical Center, Boston
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
RecruitingPhase 3
- Tufts Medical Center, Boston
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
RecruitingPhase 3
- Tufts University School of Dental Medicine, Boston
The Myelin Disorders Biorepository Project
RecruitingObservational study
- Massachusetts General Hospital (MGH), Boston
About Sjogren's Syndrome
Sjogren's Syndrome is an autoimmune disease that causes dryness of the mouth, eyes and other parts of the body. Learn how to relieve the symptoms.
More about Sjogren's Syndrome on MedlinePlus
Sjogren's Syndrome trials in other cities
- Houston, TX6 studies
- Washington, DC5 studies
- Tampa, FL4 studies
- Arlington, TX4 studies
- Charlotte, NC4 studies
- Cicero, IL4 studies
- Kansas City, MO3 studies
- Warren, MI3 studies
- Clearwater, FL3 studies
- Cypress, TX3 studies
- Tucson, AZ3 studies
- Orlando, FL3 studies
Other studies in Boston
- Breast Cancer112 studies
- Non-Small Cell Lung Cancer90 studies
- Cancer (all types)85 studies
- Metastatic Cancer63 studies
- Colorectal Cancer63 studies
- Lung Cancer62 studies
- Ovarian Cancer61 studies
- Prostate Cancer59 studies
- Depression52 studies
- Endometrial Cancer50 studies
- Heart Failure44 studies
- Acute Myeloid Leukemia44 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.